T
Instil Bio, Inc. Common StockTIL
Instil Bio is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. Instil's lead asset, AXN-2510, is a novel and differentiated PD-L1xVEGF bispecific antibody in development for the treatment of multiple solid.
US StocksBiotechnologyHealthcareSmall Cap
TIL Price Trend
Instil Bio, Inc. Common Stock · Full TradingView Chart
NASDAQ:TIL